COMMON MAPS
Map version new-york activity top-down
Main site Contact
Menu
↑ parent activity group ·
research dossier

PASTEUR FOUNDATION

NEW YORK, NY · EIN 136018861 · Form 990 · FY2024 · NTEE U50J · Science & Technology · Small ($100K-$1M) · pasteurfoundation.org
revenue
$625K
expenses
$1.0M
net assets
$1.7M
employees
2
volunteers
10
program ratio
75%
mission · from form 990

THE PASTEUR FOUNDATION SUPPORTS GRANTS FOR THE RESEARCH CARRIED OUT BY INSTITUT PASTEUR. THE FOUNDATION ALSO DEVELOPS EXCHANGES BETWEEN INSTITUT PASTEUR AND US SCIENTISTS BY WAY OF SEVERAL EXCHANGE PROGRAMS.

profile · synthesized from sources

The Pasteur Foundation is the U.S. partner of the Institut Pasteur, supporting biomedical research and scientific exchange between American and French scientists. It funds fellowships for early-career researchers, advances translational science in areas like infectious diseases and antimicrobial resistance, and fosters transatlantic collaboration. The foundation enables research that addresses global health challenges through innovation in vaccines, diagnostics, and therapeutics.

named programs · 3 · from sources

What they call their work

Pasteur 2030 Strategy
Strategic initiative focused on four pillars: Environmental Transitions and Health, Infectious Disease Threats, Origins of Disease, and Health and Disease at the Extremes of Life to guide research priorities through 2030
Pasteur Foundation Fellowship
Funds early-career scientists to conduct two-year research projects at the Institut Pasteur in Paris, working in a global research environment with scientists from over 70 countries
Translational Science Program
Accelerates the development of research into practical applications including vaccines, diagnostics, therapeutics, and gene therapies for global health impact
activities · 4 groups

What they do

  • Biomedical Research and Innovation 1 activity
    • Conducting research on infectious diseases and vaccine development
      Carries out original scientific research on infectious diseases including HIV, SARS-CoV-2, chikungunya, Zika, Lassa fever, and tuberculosis, with a focus on developing vaccines, monoclonal antibodies, diagnostic tools, and gene therapies. Includes clinical trials of mRNA vaccines and development of biosensors for pathogen detection.
  • Medical Research Funding 1 activity
    • Funding scientific fellowships for international researchers
      Awards grants to support postdoctoral and early-career researchers, particularly from the U.S., Canada, and the UK, to conduct biomedical research at the Institut Pasteur in Paris or within the Pasteur Network. Includes named fellowship programs such as the Sir Dennis and Lady Gillings Global Health Fellowship and the Lady Mireille & Sir Dennis Gillings Global Public Health Fellowship.
  • Research and Scholarly Fellowship Support 1 activity
    • Supporting scientific collaboration through exchange programs
      Operates and funds international exchange programs that facilitate scientific collaboration between U.S. researchers and the Institut Pasteur, including structured fellowship placements and mentorship opportunities to strengthen bilateral research partnerships.
  • Uncategorized 1 activity
    • Funding research at the Institut Pasteur
      Provides financial support for scientific research conducted by the Institut Pasteur in Paris and across its global network, including work on infectious diseases, vaccine development, and public health initiatives. This includes targeted funding during global health crises such as the COVID-19 pandemic.
financials · form 990 · fy2024
revenue
Total revenue$625K
Contributions & grants$607K97%
Program service revenue$00%
Investment income$18K3%
Other revenue$0
expenses
Total expenses$1.01M
Program expenses75%
Admin / overhead11%
Fundraising15%
Salaries & benefits$264K
Grants paid out$607K
Largest expense lineCompensation
balance sheet
Total assets$1.71M
Cash$411K
Investments$1.29M
Liabilities$25K
Net assets$1.68M
Liquid reserves20.2 mo
4 years on record · 2020–2024 · YoY revenue -7.9%
leadership · form 990 part vii · fy2024

Who runs it

paid leadership · 2
NameTitleHours/wkCompensation
GREGORY A CORSICO Executive Dir. 40 $127K
EMILY WARNE Executive Dir. 40 $116K
board members · 5
  • FRANCOIS MAISONROUGE — President
  • MIREILLE GILLINGS — Director
  • PABLO LEGORRETA — Director
  • PASCAL WIRZ — Director
  • STEWART COLE PhD — Director
relationships · 19

Who they work with

  • Concordia University Partner — Eligible institution whose PhD recipients can be sponsored for the Gillings Global Public Health Fellowship.
  • Enodia Therapeutics Partner — Founded Enodia Therapeutics as a spin-off to advance targeted protein degradation for treating cancer, inflammatory diseases, and viral infections.
  • Gladstone Institutes Partner — Partners in collaborative research, training, and resource sharing to address global health challenges.
  • Institut Pasteur Network — Pasteur Foundation functions as the US office of the Institut Pasteur.
  • Institut Pasteur Network — U.S. representation of the Institut Pasteur, supporting its research and global health initiatives.
  • Institut Pasteur Partner — Hosts Pasteur Foundation fellows for research at its Paris location and within the Pasteur Network.
  • Institut Pasteur Partner — Primary partner organization supported by the Pasteur Foundation to advance biomedical research and train scientists.
  • Institut Pasteur Partner — Primary research partner; recipient of grants and collaborator in scientific exchange programs.
  • Institut Pasteur Partner — Primary research partner; the foundation supports its scientific research, education, and global health initiatives.
  • Institut Pasteur Partner — Primary scientific and operational partner in advancing global public health initiatives.
  • Institut Pasteur Partner — Primary scientific partner in Paris; the Pasteur Foundation funds fellowships and research at the Institut Pasteur.
  • Institut Pasteur Partner — Supports the medical research and scientists of Institut Pasteur through fundraising and events.
  • Institut Pasteur de Saigon Partner — Established the first international Pasteur Institute in Saigon (now Ho Chi Minh City, Vietnam) in 1891.
  • Pasteur Network Network — Collaborates through the Pasteur Network of 33 institutions in 25 countries to apply research findings in real-world public health settings.
  • Pasteur Network Network — Collaborates with the Pasteur Network on surveillance, vaccine delivery, and maternal-child health programs in high-risk and low-resource regions.
  • University of California, San Francisco’s Quantitative Biosciences Institute Partner — Collaborates on research, training, and data sharing for global health and pandemic preparedness.
  • University of Cambridge Partner — Eligible institution whose PhD recipients can be sponsored for the Gillings Global Public Health Fellowship.
  • University of North Carolina – Chapel Hill Partner — Eligible institution whose PhD recipients can be sponsored for the Gillings Global Public Health Fellowship.
  • WHO Partner — Collaborates with the World Health Organization on global preparedness and pandemic response systems.
strategies · 3

How they approach the work

Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.

  • One Health Integration for Disease Prevention
    methodology: One Health
    By integrating human, animal, and environmental health research, the foundation develops comprehensive strategies to prevent diseases at their origins, shifting focus from treatment to prevention because many infectious diseases emerge at the interface of these domains.
  • Transatlantic and Global Scientific Exchange
    methodology: transatlantic_scientific_exchange
    By funding fellowships and research collaborations between U.S. and French scientists, and extending to the Global South, the foundation advances scientific progress because sustained international exchange accelerates discovery and builds global research capacity.
  • Translational Science and Technology-Driven Innovation
    methodology: translational_science
    By bridging basic research and clinical applications and leveraging advanced technologies like AI and biotechnology, the foundation accelerates the development and scaling of health innovations because technological integration shortens the path from discovery to real-world impact.